Peter Lio, MD - August 11, 2022 - The New Kids on the Block: IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis

Peter Lio, MD, LiVDerm faculty and atopic dermatitis expert, shares pearls from his session at the SBS 2022 event regarding the efficacy and safety of IL-13 inhibitors for treatment of AD.

• What factors should clinicians consider when selecting a biologic or systemic therapy to manage atopic dermatitis?
• Effectively and promptly diagnosing atopic dermatitis can be a bit tricky at times. What is your personal approach for effective diagnosis?
• Which patients would benefit most from an integrative approach to managing atopic dermatitis?
• How can clinicians execute effective shared decision-making strategies in the management of chronic skin conditions?